SCHEMBL2895345

SCHEMBL2895345

CC(C)(C)c1noc(CN2CC(Oc3ccc(-c4ccc(C(N)=O)c(F)c4)nc3)C2)n1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 3/20 0.38
NR1H4 Q96RI1 1/20 0.36
MTOR P42345 1/20 0.36
MAPK1 P28482 1/20 0.36
GRM2 Q14416 2/20 0.34
AOC3 Q16853 3/20 0.33
CSF1R P07333 2/20 0.33
FLT3 P36888 2/20 0.33
PARP10 Q53GL7 2/20 0.33
PARP15 Q460N3 1/20 0.33
PDGFRB P09619 1/20 0.33
KIT P10721 1/20 0.33
PDGFRA P16234 1/20 0.33
SYK P43405 1/20 0.33
STAT3 P40763 1/20 0.32
ACVR1 Q04771 1/20 0.32
NPC1 O15118 1/20 0.32
ALDH1A1 P00352 1/20 0.32
RAB9A P51151 1/20 0.32
GRIN1 Q05586 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13024338 0.93 MAPK1 (0.36) GPR119MTORMAPK1GRM2PARP10
SCHEMBL2896254 0.88 GPR119 (0.39) GPR119MTORMAPK1GRM2PARP10
SCHEMBL2904085 0.88 GRM2 (0.40) GPR119MTORMAPK1GRM2PARP10
SCHEMBL2894552 0.87 GRIN1 (0.41) GPR119MTORMAPK1GRM2AOC3
SCHEMBL2895545 0.87 MAPK1 (0.40) GPR119NR1H4MTORMAPK1GRM2
SCHEMBL2895794 0.87 GPR119 (0.36) GPR119MTORGRM2SYKSTAT3
SCHEMBL2891303 0.86 S1PR1 (0.38) GPR119MTORMAPK1GRM2PARP10
SCHEMBL2895333 0.85 GPR119 (0.35) GPR119MTORMAPK1GRM2PARP10
SCHEMBL6521815 0.83 GPR119 (0.40) GPR119GRM2PARP10PARP15STAT3
SCHEMBL2896029 0.81 GPR119 (0.38) GPR119MTORMAPK1GRM2PARP10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100286110-A1 AZETIDINYL G-PROTEIN COUPLED RECEPTOR AGONISTS PROSIDION LIMITED (GB) 2010-11-11 US disclosed
US-20100286110-A1 AZETIDINYL G-PROTEIN COUPLED RECEPTOR AGONISTS PROSIDION LIMITED (GB) 2010-11-11 US disclosed
US-20100286110-A1 AZETIDINYL G-PROTEIN COUPLED RECEPTOR AGONISTS PROSIDION LIMITED (GB) 2010-11-11 US disclosed
WO-2009050523-A1 AZETIDINYL G-PROTEIN COUPLED RECEPTOR AGONISTS PROSIDION LIMITED (GB) 2009-04-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100286110-A1 AZETIDINYL G-PROTEIN COUPLED RECEPTOR AGONISTS GPR119, GIPR, GPR39 GPR119 1/4885NR1H4 192/4885MTOR 2703/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.